Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126444511 | 12644451 | 1 | I | 20160726 | 20160801 | 20160811 | 20160811 | EXP | BR-PFIZER INC-2016372136 | PFIZER | 5.00 | YR | Y | 16.65000 | KG | 20160811 | PH | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126444511 | 12644451 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | Subcutaneous | 40 MG, UNK | N | M98822 | 71868 | 40 | MG | SOLUTION FOR INJECTION | |||||
| 126444511 | 12644451 | 2 | I | MERCAPTOPURINE. | MERCAPTOPURINE | 1 | Oral | 25 MG, UNK | N | 5053341 | 0 | 25 | MG | ||||||
| 126444511 | 12644451 | 3 | I | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126444511 | 12644451 | 1 | Acute lymphocytic leukaemia |
| 126444511 | 12644451 | 2 | Acute lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126444511 | 12644451 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126444511 | 12644451 | Drug interaction | |
| 126444511 | 12644451 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |